Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/34822
Title: The safety and efficacy of dual biological therapy: Dupilumab and fremanezumab.
Austin Authors: Honigman, Anthony;Oo, Hnin P;Macdonell, Richard A L ;Kern, Johannes S
Affiliation: Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Neurology
Faculty of Medicine, Dentistry and Health Services, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.;Department of Dermatology, Alfred Health, Melbourne, Victoria, Australia.;Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia.
Faculty of Medicine, Dentistry and Health Sciences, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia.
Issue Date: 8-Jan-2024
Date: 2024
Publication information: The Australasian Journal of Dermatology 2024-01-08
URI: https://ahro.austin.org.au/austinjspui/handle/1/34822
DOI: 10.1111/ajd.14205
ORCID: 0000-0002-4872-6340
0000-0003-2440-5128
0000-0001-6604-3968
0000-0001-6372-8048
Journal: The Australasian Journal of Dermatology
PubMed URL: 38189530
ISSN: 1440-0960
Type: Journal Article
Subjects: biologic therapy atopic dermatitis
biologic therapy migrane
combined biologic therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

30
checked on Nov 14, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.